Study Follow-up SR SR MBL MBL BoP BoP PD PD PCR PCR
Ti (%) Zr (%) Ti (mm) Zr (mm) Ti (%) Zr (%) Ti (mm) Zr (mm) Ti (%) Zr (%)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Benic et al. [14] 1 year 100 100* -0.46 (0.5) -0.5 (0.63)* 12.5 (12.9)
(P > 0.683)
12.7 (19.1)*
(P > 0.683)
NR NR 6.2 (12)
(P > 0.05)
3.9 (9.3)*
(P > 0.05)
Bienz et al. [15] 6 months 100 100 NR NR 32.5 (27.8)
(P < 0.05)
21.7 (23.6)
(P < 0.05)
2.6 (0.4) 2.4 (0.4) 75 (29.4)
(P < 0.0001)
68.3 (31.9)
(P < 0.0001)
Hassouna et al. [16] 5 years 100 100 -1.8 (0.24) -1.77 (0.41) NR NR 3.5 (0.6)
(P < 0.01)
3.3 (0.5)
(P < 0.01)
NR NR
Ioannidis et al. [17] 3 years 97.3 98.7* -0.38 (0.55)
(P > 0.05)
-0.5 (0.9)*
(P > 0.05)
20 (19.1)
(P > 0.05)
13.8 (17.9)*
(P > 0.05)
2.9 (0.8)
(P > 0.05)
2.6 (0.8)*
(P > 0.05)
7.7 (11.9)
(P > 0.05)
10 (16.4)*
(P > 0.05)
Koller et al. [18] 6.5 years 93.3 87.5 -1.17 (0.73)
(P > 0.05)
1.38 (0.81)
(P > 0.05)
12.6 (7.6)
(P < 0.01)
16.4 (6.16)
(P < 0.01)
NR NR 15.2 (15.58)
(P > 0.05)
11.07 (8.11)
(P > 0.05)
Müller et al. [19] 5 years 92.6 95.8* -0.61 (0.83)
(P > 0.05)
-0.6 (0.69)*
(P > 0.05)
NR NR NR NR NR NR
Osman et al. [20] 1 year 95.8 90.9 -0.18 (0.47) -0.42 (0.4) NR NR NR NR NR NR
Payer et al. [21] 2 years 100 93.3 -1.43 (0.67) -1.48 (1.05) 7.4 (3.39) 9.1 (4.34) NR NR NR NR
Siddiqi et al. [22] 1 year 98.6 91.2 -0.125 (0.34) -0.25 (0.23) NR NR 1.59 (0.5) 2.2 (0.61) NR NR
Tolentino et al. [23] 1 year 100 100* -0.35 (0.24) -0.32 (0.27)* 10 10* 3.051
(P > 0.05)
3.1*
(P > 0.05)
NR NR

*Titanium-zirconium.
SR = survival rate; MBL = marginal bone loss; BoP = bleeding on probing; PD = probing depth; PCR = plaque control record; Ti = titanium; Zr = zirconia; SD = standard deviation; NR = not reported.